Clinical Trials Logo

Genital Warts clinical trials

View clinical trials related to Genital Warts.

Filter by:

NCT ID: NCT00189293 Completed - Genital Warts Clinical Trials

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Start date: June 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the recurrence rate following total clearance of external genital warts (EGWs) when clearance has been obtained by imiquimod (3 applications per week for 4 weeks) followed by ablative therapy (laser or electrocautery therapy) with that from just ablative therapy treatment alone.

NCT ID: NCT00092534 Active, not recruiting - Cervical Cancer Clinical Trials

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

FUTURE II
Start date: June 14, 2002
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to determine if GARDASILâ„¢ (V501) is able to prevent cervical cancer.

NCT ID: NCT00092521 Completed - Cervical Cancer Clinical Trials

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Start date: December 2001
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to determine if GARDASIL (V501) with four components is able to prevent cervical cancer, cervical dysplasia, including Cervical Intraepithelial Neoplasia (CIN)(Any Grade) and Adenocarcinoma In Situ (AIS), and genital warts.

NCT ID: NCT00092495 Completed - Cervical Cancer Clinical Trials

Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)

Start date: December 2002
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to determine if an investigational vaccine Gardasil (V501) with 4 components will provide an immune response and will be well tolerated in pre-adolescents and adolescents.

NCT ID: NCT00092482 Completed - Cervical Cancer Clinical Trials

Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)

Start date: June 28, 2002
Phase: Phase 3
Study type: Interventional

The purpose of the study is to determine if an investigational vaccine with a single component develops an immune response that is similar to the equivalent investigational vaccine with four components to reduce cervical disease.